AstraZeneca shares leap with FDA set to review drug to treat breast cancer

1 month ago 53
AstraZeneca shares rallied on Wednesday after the U.K. giant and its Japanese partner said the Food and Drug Administration was reviewing one of its drugs to treat breast cancer.
Read Entire Article
  1. Homepage
  2. category-label-
  3. AstraZeneca shares leap with FDA set to review drug to treat breast cancer

Related

Worried about a drop in tech stocks? How to play defense with your portfolio.

Worried about a drop in tech stocks? How to play defense wit...

36 minutes ago 1
Bitcoin slips below $100,000 for first time since June. Here’s where it might be headed next.

Bitcoin slips below $100,000 for first time since June. Here...

1 hour ago 1
A deeper dive into Fed rate cuts and China trade reveals these investing ideas

A deeper dive into Fed rate cuts and China trade reveals the...

1 hour ago 1

Trending

Popular

Asia Morning Briefing: What's the Real Use for a Yen Stablecoin? An On-Chain Carry Trade

Asia Morning Briefing: What's the Real Use for a Yen Stablec...

5 days ago 101
Indonesia’s digital rupiah CBDC to get stablecoin twist with government bond backing

Indonesia’s digital rupiah CBDC to get stablecoin twist with...

5 days ago 90
Bitchat hits No. 2 on app charts in Jamaica as Hurricane Melissa strikes

Bitchat hits No. 2 on app charts in Jamaica as Hurricane Mel...

5 days ago 84
The Protocol: ETH’s Fusaka Upgrade Goes Live on Hoodi, Mainnet Next

The Protocol: ETH’s Fusaka Upgrade Goes Live on Hoodi, Mainn...

6 days ago 67
Trump could give automakers relief from Nexperia chip shortage

Trump could give automakers relief from Nexperia chip shorta...

3 days ago 62
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Tayedi Search engine 2025. All rights are reserved